Teraplast SA

As of June 30, 2026, Teraplast SA carries a market capitalization of 1.28B, placing it among publicly traded companies globally. Its enterprise value stands at 1.72B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Teraplast SA's next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Teraplast SA has 3.00B shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Teraplast SA maintains a current ratio of 1.07, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Teraplast SA recorded 3.21M in income tax expense.

As of the close on October 22, 2026, Teraplast SA's stock has declined approximately 6.56% over the past 52 weeks. The 50-day moving average sits at 0.40, while the 200-day moving average is 0.45.

As of June 30, 2026, Teraplast SA holds 54.31M in cash and equivalents against 462.26M in total debt, resulting in a net debt position of 386.68M. Total book value stands at 393.48M, with working capital of 45.50M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Teraplast SA's most recent stock split took place on September 24, 2025 with a 399:499 split ratio.